Axsome Therapeutics, Inc. (AXSM) Social Stream
AXSOME THERAPEUTICS INC (AXSM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AXSOME THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $180 | $34 | $98.272 | $81.99 | 19.86% |
| 2021-12-17 | 11 | $180 | $34 | $98.272 | $81.99 | 19.86% |
| 2021-12-20 | 11 | $180 | $26 | $95.727 | $81.99 | 16.75% |
| 2022-03-02 | 11 | $180 | $26 | $89.363 | $81.99 | 8.99% |
| 2022-03-07 | 11 | $180 | $31 | $88.454 | $81.99 | 7.88% |
| 2022-03-29 | 11 | $180 | $31 | $89.909 | $81.99 | 9.66% |
| 2022-04-21 | 11 | $180 | $34 | $90.454 | $81.99 | 10.32% |
| 2022-04-25 | 11 | $180 | $34 | $90.272 | $81.99 | 10.1% |
| 2022-04-27 | 11 | $180 | $27 | $88.181 | $81.99 | 7.55% |
| 2022-05-03 | 11 | $180 | $27 | $87.727 | $81.99 | 7% |
| 2022-06-02 | 11 | $180 | $27 | $84.1 | $81.99 | 2.57% |
| 2022-07-11 | 10 | $180 | $28 | $89.4 | $81.99 | 9.04% |
| 2022-08-10 | 10 | $180 | $28 | $89.5 | $81.99 | 9.16% |
| 2022-08-13 | 10 | $180 | $28 | $87.1 | $81.99 | 6.23% |
| 2022-08-21 | 10 | $180 | $34 | $90.6 | $81.99 | 10.5% |
| 2022-08-23 | 10 | $180 | $34 | $101.5 | $81.99 | 23.8% |
| 2022-09-02 | 10 | $210 | $34 | $106.5 | $81.99 | 29.89% |
| 2022-09-17 | 11 | $210 | $34 | $109.2 | $81.99 | 33.19% |
| 2022-10-04 | 11 | $210 | $34 | $108.1 | $81.99 | 31.85% |
| 2022-10-13 | 12 | $210 | $34 | $108.4 | $81.99 | 32.21% |
| 2022-10-24 | 12 | $210 | $35 | $104.272 | $81.99 | 27.18% |
| 2022-11-04 | 13 | $210 | $35 | $103.5 | $81.99 | 26.23% |
| 2022-11-08 | 13 | $210 | $35 | $103.416 | $81.99 | 26.13% |
| 2022-11-09 | 13 | $210 | $35 | $103.75 | $81.99 | 26.54% |
| 2022-11-18 | 13 | $210 | $34 | $105 | $81.99 | 28.06% |
| 2022-11-28 | 13 | $210 | $35 | $105.083 | $81.99 | 28.17% |
| 2022-11-29 | 13 | $210 | $34 | $108.416 | $81.99 | 32.23% |
| 2023-01-03 | 14 | $210 | $52 | $109 | $81.99 | 32.94% |
| 2023-01-26 | 15 | $210 | $52 | $106.571 | $81.99 | 29.98% |
| 2023-02-14 | 15 | $210 | $52 | $107 | $81.99 | 30.5% |
| 2023-02-28 | 15 | $210 | $52 | $107.357 | $81.99 | 30.94% |
| 2023-03-13 | 15 | $210 | $52 | $107.857 | $81.99 | 31.55% |
| 2023-03-20 | 15 | $200 | $52 | $107.142 | $81.99 | 30.68% |
| 2023-04-05 | 15 | $200 | $52 | $106.785 | $81.99 | 30.24% |
| 2023-04-17 | 15 | $200 | $52 | $106.642 | $81.99 | 30.07% |
| 2023-04-27 | 15 | $200 | $52 | $105.2 | $81.99 | 28.31% |
| 2023-05-09 | 15 | $200 | $57 | $105.533 | $81.99 | 28.71% |
| 2023-05-10 | 15 | $200 | $57 | $107.5 | $81.99 | 31.11% |
| 2023-06-07 | 15 | $200 | $57 | $109 | $81.99 | 32.94% |
| 2023-06-12 | 15 | $200 | $57 | $109.214 | $81.99 | 33.2% |
| 2023-06-23 | 15 | $200 | $57 | $109.928 | $81.99 | 34.07% |
| 2023-07-11 | 14 | $200 | $57 | $111.23 | $81.99 | 35.66% |
| 2023-07-13 | 14 | $200 | $59 | $111.384 | $81.99 | 35.85% |
| 2023-07-25 | 14 | $190 | $59 | $110.923 | $81.99 | 35.29% |
| 2023-08-08 | 14 | $190 | $81 | $114.153 | $81.99 | 39.23% |
| 2023-08-11 | 14 | $180 | $81 | $113.384 | $81.99 | 38.29% |
| 2023-09-05 | 14 | $180 | $84 | $113.615 | $81.99 | 38.57% |
| 2023-10-12 | 13 | $180 | $84 | $114.916 | $81.99 | 40.16% |
| 2023-10-26 | 12 | $180 | $84 | $116.727 | $81.99 | 42.37% |
| 2023-11-08 | 12 | $180 | $80 | $116.363 | $81.99 | 41.92% |
| 2023-12-07 | 12 | $180 | $80 | $115.454 | $81.99 | 40.81% |
The Trend in the Analyst Price Target
AXSM's average price target has moved up $6.25 over the prior 15 months.
AXSM reports an average of 55.26% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 15 | 210 | 52 | 106.571 | 70.81 | 50.5% |
| 2023-05-09 | 15 | 200 | 57 | 105.533 | 76.74 | 37.52% |
| 2023-06-23 | 14 | 200 | 57 | 109.928 | 88.11 | 24.76% |
| 2023-09-05 | 13 | 180 | 84 | 113.615 | 78.77 | 44.24% |
| 2023-12-07 | 12 | 180 | 80 | 115.454 | 70.23 | 64.39% |
AXSM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 10 | 0 | 2 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 23 months, AXSM's average broker recommendation rating improved by 0.12.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AXSM as an investment opportunity.
- AXSM has a lower variance in analysts' estimates than -5482.02% of all US stocks.
- AXSOME THERAPEUTICS INC's average analyst price target is greater than 5141.22% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, AXSOME THERAPEUTICS INC's number of analysts covering the stock is greater than 5047.67% of them.
- AXSM has a higher upside potential (average analyst target price relative to current price) than 1447.09% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, MCRB, ASND, and RVNC are the three stocks most similar to AXSOME THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!